Share ownership Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse Other stock markets 01:30:02 14/03/2026 am IST			After hours 05:30:00 am
985.08 ^USD	+0.80%		985.00	-0.01%

14/03	Healthcare Stocks Post Small Losses -- Healthcare Roundup	DJ
13/03	The Kroger Co Brings Zepbound KwikPen To Retail Pharmacy Expanding Access And Savings For Self-Pay Patients	CI

Share class: Eli Lilly and Company

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	94,96,80,694	94,78,47,779 ( 99.81 %)	3,65,000 ( 0.0384 %)	99.81 %

Major shareholders: Eli Lilly and Company

Name	Equities	%	Valuation
Lilly Endowment, Inc. 9.773 %	9,21,90,516	9.773 %	96 984 M $
Lilly Endowment, Inc. 9.741 %	9,18,96,978	9.741 %	96 675 M $
Vanguard Fiduciary Trust Co. 8.689 %	8,19,65,974	8.689 %	86 227 M $
PNC Wealth Management LLC 5.42 %	5,11,26,580	5.42 %	53 785 M $
BlackRock Advisors LLC 5.302 %	5,00,14,607	5.302 %	52 615 M $
STATE STREET CORPORATION 3.749 %	3,53,61,916	3.749 %	37 200 M $
Fidelity Management & Research Co. LLC 2.723 %	2,56,84,557	2.723 %	27 020 M $
Capital Research & Management Co. (Global Investors) 2.604 %	2,45,66,846	2.604 %	25 844 M $
Geode Capital Management LLC 2.1 %	1,98,10,065	2.1 %	20 840 M $
Eaton Vance Management 1.653 %	1,55,93,018	1.653 %	16 404 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.00107 %	3,03,030	0.00107 %	11 M $
Safra Asset CTVM SA (Investment Management) 0.000164 %	46,600	0.000164 %	2 M $
Morgan Stanley Administradora de Carteiras SA 0.000065 %	18,460	0.000065 %	642 888 $
Itaú Unibanco SA 0.000044 %	12,544	0.000044 %	436 858 $
XP Allocation Asset Management Ltda. 0.000034 %	9,619	0.000034 %	334 991 $
Empiricus Gestao De Recursos Ltda. 0.000033 %	9,369	0.000033 %	326 285 $
XP Advisory Gestão Recursos Ltda. 0.000019 %	5,310	0.000019 %	184 926 $
BTG Pactual Gestão E Consultoria De Investimentos Ltda. 0.000008 %	2,290	0.000008 %	79 752 $
Santander Distribuidora de Titulos e Valores Mobiliários SA 0.000004 %	1,036	0.000004 %	36 080 $
Banco Santander Brasil SA (Private Banking) 0 %	138	0 %	4 806 $

Breakdown by shareholder type

Institutional	81.55%
Other	6.2%
State Street Corp.	3.75%
Schweizerische Nationalbank	0.23%
Sumitomo Mitsui Trust Group, Inc.	0.2%
Swedbank AB	0.18%
Individuals	0.16%
Manulife Financial Corp.	0.15%
Governments	0.12%
Danske Bank A/S	0.07%
SEI Investments Co.	0.07%
Fifth Third Bancorp	0.05%
Rathbones Group Plc	0.04%
Skandinaviska Enskilda Banken AB	0.04%
The Bank of Nova Scotia	0.04%
Regions Financial Corp.	0.04%
ABN AMRO Bank NV	0.03%
Polar Capital Holdings Plc	0.03%
Menora Mivtachim Holdings Ltd.	0.03%
Zurich Insurance Group AG	0.02%
ING Groep NV	0.02%
Münchener Rückversicherungs-Gesellschaft AG	0.01%
Associated Banc-Corp	0.01%
Banco Bilbao Vizcaya Argentaria SA	0.01%
The Allstate Corp.	0.01%
Peapack-Gladstone Financial Corp.	0.01%
Clal Insurance Enterprises Holdings Ltd.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Migdal Insurance & Financial Holdings Ltd.	0.01%
Unknown	6.9%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	76.95%
United Kingdom	7.19%
Canada	1.71%
Norway	1.39%
France	0.9%
Sweden	0.72%
Japan	0.58%
Switzerland	0.57%
Australia	0.52%
Netherlands	0.34%
Denmark	0.33%
Germany	0.32%
South Korea	0.25%
Hong Kong	0.23%
Individuals	0.16%
Luxembourg	0.13%
Italy	0.12%
Belgium	0.12%
Ireland	0.1%
Finland	0.06%
Israel	0.06%
Liechtenstein	0.06%
Spain	0.04%
Singapore	0.04%
Austria	0.04%
New Zealand	0.04%
Brazil	0.04%
Malaysia	0.03%
Czech Republic	0.02%
Slovenia	0.01%
South Africa	0.01%
China	0.01%
Taiwan	0.01%

Based on 1000 largest holdings

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (74%): products for treating osteoporosis, diabetes, and growth problems; - oncology (14.4%); - immunology diseases (8.1%); - neurology (2.1%): primarily drugs used in treating depression and schizophrenia; - other (1.4%). Net sales are distributed geographically as follows: the United States (66.7%), Europe (17.7%), Japan (3.2%), China (3%) and other (9.4%).

Employees

50,000

Sector

Pharmaceuticals

More about the company